Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Disasters Averted Previous | All Articles This Week | Next
This article originally posted 09 January, 2012 and appeared in  Safety and Error PreventionDiabetes Clinical Mastery Series Issue 66Prescription Errors

Diabetes Disaster Averted #66: Beware of Similar Names

I work as a staff pharmacist at a community hospital in the Northeast. I received an order via POM for Nevirapine (brand = Viramune) 500 mg po BID. Since Viramune (an anti-retroviral medication) comes at 200 mg strength I decided to look into this order. I could not find any order history of this patient ever receiving this medication nor could I find such an indication for use in this patient....

Advertisement

The floor nurse showed me the MAR from the nursing home and there it was in black and white: Viramune 500 mg po BID. I decided to call the nursing home.

The nursing home nurse confirmed the patient receives Viramune twice daily after reviewing the patient's MAR. I asked her to get the patient's stored supply and actually read the dose and the pharmacy name. She retrieved the bottle (which she described as a box) and read the labeling. "Viramune 500 mg capsules," she continued, "for use as an immune booster."

That was the answer: this product is an herbal supplement with the same exact name as the anti-retroviral medication Viramune. After searching the internet I did come across ViRamune herbal supplements from a company named Trilight which makes both a liquid and a 500 mg dosage form of their product.

I contacted the doctor to report my findings. The doctor cancelled the order and dictated an addendum to the admission note saying that this patient does not take Viramune.

Lesson Learned:

There are numerous products with similar names. When in doubt check the patients profile for past medications and indications and where possible ask the patient why they are taking the medication.

Donna Ciulla, R.Ph.
 
Courtesy Institute of Safe Medication Practices (www.ismp.org)
 

Report Medication Errors to ISMP:

Diabetes in Control is partnered with the Institute for Safe Medication Practices (ISMP) to help ensure errors and near-miss events get reported and shared with millions of health care practitioners. The ISMP is a Patient Safety Organization obligated by law to maintain the anonymity of anyone involved, as well as omitting or changing contextual details for that purpose. Help save lives and protect patients and colleagues by confidentially reporting errors to the ISMP.

Report_Now

*****

And if you have a "Diabetes Disaster Averted" story, please also send it in separately to Diabetes In Control. If we use it you will receive a Visa Gift Card worth $50.00. Click here to let us know the details. (You can use your name or remain anonymous if you prefer.) Please note that ISMP is not associated with this Gift Card promotion.

For more Diabetes Disasters Averted, just follow this link.

 

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 09 January, 2012 and appeared in  Safety and Error PreventionDiabetes Clinical Mastery Series Issue 66Prescription Errors

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:
Search Articles On Diabetes In Control